The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125843621 12584362 1 I 20151202 20160722 20160722 EXP IT-MYLANLABS-2015M1044610 MYLAN LOMBARDI G, PAMBUKU A, BELLU L, DELLA PUPPA A, RUMANO L, GARDIMAN MP, ET AL. CISPLATIN AND TEMOZOLOMIDE COMBINATION IN THE TREATMENT OF SUPRATENTORIAL ANAPLASTIC EPENDYMOMA. CHEMOTHERAPY 2014; 59(3):176-180. 0.00 Y 0.00000 20160722 MD IT IT

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125843621 12584362 1 PS CISPLATIN. CISPLATIN 1 Intravenous drip 60 MIN INFUSION ON DAY 1 AT DOSE OF 75 MG/M2 WITH HYDRATION; TREATMENT REPEATED EVERY 21 DAYS U 91062 INJECTION
125843621 12584362 2 SS TEMOZOLOMIDE. TEMOZOLOMIDE 1 Oral 5 CONSECUTIVE DAYS AT 150MG/M2 SINGLE DOSE; TREATMENT REPEATED EVERY 21 DAYS U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125843621 12584362 1 Ependymoma malignant
125843621 12584362 2 Ependymoma malignant

Outcome of event

Event ID CASEID OUTC COD
125843621 12584362 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125843621 12584362 Alopecia
125843621 12584362 Anaemia
125843621 12584362 Fatigue
125843621 12584362 Nausea
125843621 12584362 Nephropathy toxic
125843621 12584362 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found